336 related articles for article (PubMed ID: 20606680)
1. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Lugli A; Iezzi G; Hostettler I; Muraro MG; Mele V; Tornillo L; Carafa V; Spagnoli G; Terracciano L; Zlobec I
Br J Cancer; 2010 Jul; 103(3):382-90. PubMed ID: 20606680
[TBL] [Abstract][Full Text] [Related]
2. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
[TBL] [Abstract][Full Text] [Related]
3. Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer.
Kalantari E; Taheri T; Fata S; Abolhasani M; Mehrazma M; Madjd Z; Asgari M
World J Surg Oncol; 2022 Jan; 20(1):15. PubMed ID: 35016698
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma.
Okada T; Nakamura T; Watanabe T; Onoda N; Ashida A; Okuyama R; Ito K
PLoS One; 2014; 9(4):e94487. PubMed ID: 24727741
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma.
Eom DW; Hong SM; Kim G; Bae YK; Jang KT; Yu E
Appl Immunohistochem Mol Morphol; 2015; 23(10):682-8. PubMed ID: 25710579
[TBL] [Abstract][Full Text] [Related]
6. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
[TBL] [Abstract][Full Text] [Related]
7. Molecular markers in circulating tumour cells from metastatic colorectal cancer patients.
Gazzaniga P; Gradilone A; Petracca A; Nicolazzo C; Raimondi C; Iacovelli R; Naso G; Cortesi E
J Cell Mol Med; 2010 Aug; 14(8):2073-7. PubMed ID: 20597995
[TBL] [Abstract][Full Text] [Related]
8. CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma.
Mărgaritescu C; Pirici D; Cherciu I; Bărbălan A; Cârtână T; Săftoiu A
J Gastrointestin Liver Dis; 2014 Jun; 23(2):161-70. PubMed ID: 24949608
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
10. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
[TBL] [Abstract][Full Text] [Related]
11. Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer.
Goossens-Beumer IJ; Zeestraten EC; Benard A; Christen T; Reimers MS; Keijzer R; Sier CF; Liefers GJ; Morreau H; Putter H; Vahrmeijer AL; van de Velde CJ; Kuppen PJ
Br J Cancer; 2014 Jun; 110(12):2935-44. PubMed ID: 24786601
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.
Wang X; Hu JF; Tan Y; Cui J; Wang G; Mrsny RJ; Li W
PLoS One; 2014; 9(5):e95915. PubMed ID: 24787949
[TBL] [Abstract][Full Text] [Related]
14. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
15. ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
Hostettler L; Zlobec I; Terracciano L; Lugli A
World J Gastroenterol; 2010 Feb; 16(6):732-9. PubMed ID: 20135722
[TBL] [Abstract][Full Text] [Related]
16. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
Horst D; Kriegl L; Engel J; Kirchner T; Jung A
Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
